ERNA institutional ownership changes in Q1 2026: 7 institutions opened or added positions, 3 trimmed or exited. ERNA (Ernexa Therapeutics Inc.) is held by 12 institutional investors as of Q1 2026. Top institutional shareholders: Corient Private Wealth LP ($87,181), Geode Capital Management, LLC ($48,643), XTX Topco Ltd ($10,813). Net institutional sentiment: Bullish.
Who's Trading
Latest move
Source dates: Price Nov 3, 2026 · Insiders Feb 17, 2026 · Activists Oct 30, 2026 · Congress none
Top Holders
Continue exploring
Questions investors ask about ERNA
Who owns ERNA?
12 institutional investors held ERNA on March 31, 2026, led by Corient Private Wealth LP ($87,181), Geode Capital Management, LLC ($48,643) and XTX Topco Ltd ($10,813).
How many hedge funds hold ERNA?
12 institutional investors reported ERNA in their 13F filings for the quarter ended March 31, 2026, $179,475 in all.
Are institutions buying or selling ERNA?
Buying, on balance. In Q1 2026, 7 institutions opened or added to positions in ERNA and 3 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer
